<DOC> 
<DOCNO>1040213_business_story_2891171.utf8</DOCNO> 
<TEXT> 

The Telegraph - Calcutta : Business
 Friday, February 13, 2004 				 Bonus booster from Wockhardt, Alembic
 OUR CORRESPONDENT 																								Mumbai, Feb. 12: Two pharmaceutical companies today rewarded their shareholders with bonus issues. 																								Wockhardt has declared a bonus of one share for every two held. The firm also split its share from Rs 10 to Rs 5.																								The Ahmedabad-based Alembic also surprised the market with a generous bonus of two shares for every share held.																								On bourses today, both scrips were much sought after by investors enthused by the announcements. Wockhardt shot up by Rs 94.05 to close at Rs 894.30. The share had opened at Rs 806 and hit an intra-day high of Rs 934.																								The Alembic scrip opened at Rs 345 and remained locked in the 20 per cent upper circuit limit and finally ended the day at Rs 408.60. 																								Wockhardt also announced the consolidated financial results for the fourth quarter of 2003. Net profit at Rs 50 crore recorded a 300 per cent rise over the corresponding previous period. The company also announced an enhanced 75 per cent dividend. 																								The bonus and share split will boost liquidity and marketability of shares and will empower our shareholders, chairman Habil Khorakiwala said. 																								From the managements point of view, the bonus issue reflects the robust performance in 2003 and its confidence to perform in the emerging global pharmaceutical market. Our business in the US grew over 200 per cent in 2003 and we hope to do well this year too, he said.																								The company is planning to file around 15 abbreviated new drug applications (ANDAs) this year with some of them being patent challenges, indicating its ambitious ideas for generic drugs. Last year, the company had filed six such applications. 
</TEXT> 
</DOC>